Menu
Equities By Region UK Europe Pharmaceuticals & Health

AstraZeneca share price: Group to stockpile drugs ahead of Brexit

AstraZeneca (LON:AZN) (LON:AZN) is set to increase its drugs stockpiles in Europe by about 20 percent in preparation for a no-deal Brexit, the BBC has reported. The news comes as British engine maker Rolls-Royce Holdings (LON:RR) also signalled plans to stockpile key parts within months as it braces for a disorderly Brexit.

AstraZeneca’s share price has been little changed in today’s session, having inched 0.02 percent higher at 5,610.00p, marginally underperforming the benchmark FTSE 100 index which currently stands 0.20 percent higher at 7,699.50 points. The group’s shares have added just under 10 percent to their value over the past year, as compared with a near three-percent rise in the Footsie.

AstraZeneca to stockpile drugs

Juliette White, vice-president of global external manufacturing at AstraZeneca, told the BBC’s Newsnight programme this week that the company had been planning for a potential no-deal Brexit ever since the June 2016 referendum.

“Ultimately – and as a safety net – we will increase the amount of finished medicines available to pharmacies and hospitals in those countries,” White said, as quoted by the newswire, referring to both the UK and the European Union, adding that the blue-chip pharmco always had an additional amount of medicines available and was increasing that by about 20 percent.

The comments came after the European Medicines Agency warned earlier this month that it had identified gaps in industry preparedness for Brexit.

Analysts on blue-chip pharmco

Deutsche Bank reaffirmed the group as a ‘buy’ last week, while lifting its price target on the shares from 5,700p to 6,000p. According to MarketBeat, the Anglo-Swedish drugmaker currently has a consensus ‘buy’ rating and an average price target of 5,445.55p.

AstraZeneca is scheduled to update investors on its second-quarter and half-year performance on July 26.

As of 10:08 BST, Friday, 20 July, AstraZeneca plc share price is 5,602.00p.

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.